DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Camptothecin is an investigational drug.
There have been 93 clinical trials for Camptothecin. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 1998.
The most common disease conditions in clinical trials are Lung Neoplasms, Small Cell Lung Carcinoma, and Lymphoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Astex Pharmaceuticals, and University of New Mexico.
Recent Clinical Trials for Camptothecin
|Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers||National Cancer Institute (NCI)||Phase 2|
|Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers||Southwest Oncology Group||Phase 2|
|FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer||National Cancer Institute (NCI)||Phase 2|